These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 2848680
1. [Biochemical effects of electroconvulsotherapy]. Benkelfat C. Encephale; 1988; 14(4):273-81. PubMed ID: 2848680 [Abstract] [Full Text] [Related]
2. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy. Lerer B. Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329 [Abstract] [Full Text] [Related]
3. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action. Kleinrok Z, Wielosz M. Pol J Pharmacol Pharm; 1985 Mar; 37(6):745-52. PubMed ID: 3008135 [Abstract] [Full Text] [Related]
4. Receptors and the mechanism of action of ECT. Lerer B, Belmaker RH. Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347 [No Abstract] [Full Text] [Related]
5. Neurobiological correlates of the antidepressant action of electroconvulsive therapy. Mann JJ. J ECT; 1998 Sep; 14(3):172-80. PubMed ID: 9773356 [Abstract] [Full Text] [Related]
6. Relationship of neurotransmitters to the symptoms of major depressive disorder. Nutt DJ. J Clin Psychiatry; 2008 Sep; 69 Suppl E1():4-7. PubMed ID: 18494537 [Abstract] [Full Text] [Related]
7. Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies. Mann JJ, Kapur S. Psychopharmacol Bull; 1994 Sep; 30(3):445-53. PubMed ID: 7878181 [Abstract] [Full Text] [Related]
8. Clinical strategies for evaluating ECT mechanisms--pharmacological, biochemical and psychophysiological approaches. Lerer B, Sitaram N. Prog Neuropsychopharmacol Biol Psychiatry; 1983 Sep; 7(2-3):309-33. PubMed ID: 6137030 [Abstract] [Full Text] [Related]
9. Neurochemical mechanisms of action of ECS: evidence from in vivo studies. Newman ME, Gur E, Shapira B, Lerer B. J ECT; 1998 Sep; 14(3):153-71. PubMed ID: 9773355 [Abstract] [Full Text] [Related]
10. [A new concept of antidepressant drugs action: clinical and preclinical data]. Płaźnik A, Kostowski W. Psychiatr Pol; 1994 Sep; 28(1):39-50. PubMed ID: 7910691 [Abstract] [Full Text] [Related]
11. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor SR. Biol Psychiatry; 1983 Nov; 18(11):1301-10. PubMed ID: 6317065 [Abstract] [Full Text] [Related]
12. Effects of gabaergic and serotoninergic systems on hypothalamic content of catecholamines during sexual development in female rats. Rondina D, Ponzo OJ, Szwarcfarb B, Carbone S, Scacchi P, Moguilevsky JA. Neuro Endocrinol Lett; 2003 Nov; 24(1-2):46-9. PubMed ID: 12743531 [Abstract] [Full Text] [Related]
13. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test. Zarrindast MR, Sahebgharani M, Burnham WM. Eur Neuropsychopharmacol; 2004 Dec; 14(6):509-14. PubMed ID: 15589391 [Abstract] [Full Text] [Related]
17. Effects of electroconvulsive shock on central GABA-ergic mechanisms. Wielosz M, Stelmasiak M, Ossowska G, Kleinrok Z. Pol J Pharmacol Pharm; 1985 May; 37(2):113-22. PubMed ID: 2995953 [Abstract] [Full Text] [Related]